Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin and/or Greater Occipital Nerve Block for Patients With Chronic Migraine

NCT07535723 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT07535723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07535723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin and/or Greater Occipital Nerve Block for Patients With Chronic Migraine
Lead sponsor
Beni-Suef University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
December 31, 2026
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine headache, combination therapy, greater occipital nerve block, onabotulinumtoxina